We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ALPHARETTA, Ga., Oct. 6 /CNW/ -- Cellu Tissue Holdings, Inc. (NYSE: CLU), a North American producer of tissue products, today reported net sales of $136.6 million and a net loss of $3.8 million...
Cellu Tissue Holdings, Inc. Announces Second Quarter Fiscal 2011 Results PR Newswire ALPHARETTA, Ga., Oct. 6 ALPHARETTA, Ga., Oct. 6 /PRNewswire-FirstCall/ -- Cellu Tissue Holdings, Inc. (NYSE:...
ALPHARETTA, Ga., Sept. 27 /CNW/ -- Cellu Tissue Holdings, Inc. (NYSE: CLU) will release its second quarter fiscal 2011 financial results after the close of the New York Stock Exchange on...
Cellu Tissue Holdings, Inc. to Release Second Quarter Fiscal 2011 Results PR Newswire ALPHARETTA, Ga., Sept. 27 ALPHARETTA, Ga., Sept. 27 /PRNewswire-FirstCall/ -- Cellu Tissue Holdings, Inc...
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Cellu Tissue Holdings, Inc. (NYSE: CLU...
The Law Offices of Vincent Wong is investigating the Board of Directors of Cellu Tissue Holdings, Inc. (NYSE: CLU) for possible breaches of fiduciary duty and other violations...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cellu Tissue Holdings, Inc. (“Cellu” or the “Company”...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/clu) is investigating potential claims against the board of directors of Cellu Tissue Holdings Inc. ("Cellu Tissue" or the...
The Law Office of Abe Shainberg is investigating the Board of Directors of Cellu Tissue Holdings, Inc. (NYSE: CLU) for possible breaches of fiduciary duty and other violations...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Cellu Tissue Holdings, Inc. (“Cellu Tissue Holdings” or the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions